Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular Carcinoma

Published:2013 Issue:2 Volume:84 Page:108-114
ISSN:1423-0232
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Nakano Masahito,Tanaka Masatoshi,Kuromatsu Ryoko,Nagamatsu Hiroaki,Sakata Kenji,Matsugaki Satoru,Kajiwara Masahiko,Fukuizumi Kunitaka,Tajiri Nobuyoshi,Matsukuma Norito,Sakai Terufumi,Ono Noriyuki,Yano Yoichi,Koga Hironori,Kurogi Junichi,Takata Akio,Sumie Shuji,Satani Manabu,Yamada Shingo,Niizeki Takashi,Aino Hajime,Iwamoto Hideki,Torimura Takuji,Sata Michio

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference32 articles.

1. Global Cancer Statistics, 2002

2. Rising Incidence of Hepatocellular Carcinoma in the United States

3. Hepatocellular Carcinoma: Epidemiology, Risk Factors, and Screening

4. Early hepatocellular carcinoma as an entity with a high rate of surgical cure

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein induced by vitamin K absence or antagonist II: Experience to date and future directions;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

2. Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma;Expert Review of Molecular Diagnostics;2022-03-04

3. Impact of psoas muscle index assessed by a simple measurement method on tolerability and duration of continued treatment with sorafenib in hepatocellular carcinoma patients;European Journal of Gastroenterology & Hepatology;2022-01-31

4. Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib;European Journal of Gastroenterology & Hepatology;2020-11-10

5. Indication of suitable transarterial chemoembolization and multikinase inhibitors for intermediate stage hepatocellular carcinoma;Oncology Letters;2020-02-17